Matthew Schmidt, M.B.A, M.D.



Centennial, COSchmidt


College: BS Chemistry, Creighton University
Graduate School: MBA, Creighton University, Heider College of Business
Medical School: MD, Creighton University, School of Medicine

Professional Interests

Nuclear Medicine, body, and chest.


​Playing and watching sports, going to concerts, playing the bass guitar, playing pub trivia and watching movies.​

What are your favorite things to do in the Denver Area?

I love all of my Denver sports teams - if there is a game on I am watching. I'm excited to re-learn snowboarding, all of the R1's bought the same ski pass so we have carpools ready all winter. And nothing beats a show at Red Rocks.

What is the biggest strength of our Program?

The greatest strength of our program is the volume and breadth of studies read while on day rotations and especially on call, where you will read studies from each and every type of modality. Being able to train in the university setting and in a county hospital, you'll experience the full breadth of radiology - from complex cancer cases read on a daily basis out of the emergency department, to very complex trauma. The attendings are great and are available 24/7 to assist you as much as you need.

The same applies to IR. High volume and high acuity cases are experienced on a daily basis while on rotation. Don't expect to be anything other than a great diagnostic and/or interventional radiologist when you graduate.  


• Major A, Hammes A, Schmidt MQ, Morgan R, Abbott D, Kamdar M. Evaluating novel PET-CT functional parameters TLG and TMTV in differentiating low-grade versus grade 3A follicular lymphoma. Currently

under review.

• Schmidt MQ, Trenbeath Z, Chin BB. Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor. World Journal of Nuclear Medicine. 2019;18(3):304-306.

• Vargas CE, Schmidt MQ, Niska JR, Hartsell WF, Keole SR, Doh L, Chang JH, Sinesi C, Rodriquez R, Pankuch M, Larson GL. Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer. Advances in Radiation Oncology. 2018; 3(3):322-330. PMID: 30202801.

• Schmidt MQ, Hafertepe M, Fortuna R, Abdullah I, Richardson R. Cervical left pulmonary artery. Journal of Surgical Case Reports. 2018; 2018(1). PMID: 29383237.

• Schmidt MQ, Schraml FV. Absent Cerebellar Circulation with Intact Cerebral Blood Flow on a 99mTc Bicisate "Brain Death" Study. Clinical Nuclear Medicine. 2017; 42(12):983-984. PMID: 29076900

• Schmidt MQ, David J, Yoshida EJ, Scher K, Mita A, Shiao SL, Ho AS, Zumsteg ZS. Predictors of survival in head and neck mucosal melanoma. Oral Oncology. 2017; 73:36-42. PMID: 2893907

• Schmidt MQ, Saquilayan YJ, Domfeh N. Streptococcus pneumoniae pneumonia, endocarditis, and meningitis. ACP Hospitalist. 2016; 10(3):41.

• Falbo MA, Schmidt MQ, Greving TA, Davidson MT, McHale WA, Latta MA, Gross SM. The effect of counterion, concentration, and temperature on the release of bioavailable calcium and phosphate ions from ion permeable microcapsules for remineralization. In: Patil A, Ferritto MS, eds. Polymers for Personal Care and Cosmetics. Washington D.C.: American Chemical Society; 2013.​